Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like 5 Israeli startups seeking cures for rare genetic diseases May 14, 2018 If pharma looks slow to adopt AI, it’s got good reason, expert says May 2, 2019 Israel Innovation Authority, Mayo Clinic set up joint healthcare program May 19, 2019
